Cargando…
Investigating the challenges and opportunities for medicines management in an NHS field hospital during the COVID-19 pandemic
INTRODUCTION: Hospital admissions from COVID-19 initially increased rapidly within the UK. National Health Service (NHS) field hospitals are part of a capacity building response built at great scale and speed to respond to the anticipated increased demand the NHS faces during this time. NHS Nighting...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788195/ https://www.ncbi.nlm.nih.gov/pubmed/33277234 http://dx.doi.org/10.1136/ejhpharm-2020-002364 |
_version_ | 1783632982335029248 |
---|---|
author | de Val, Jennifer Sohal, Gurjit Sarwar, Asif Ahmed, Haseeb Singh, Inderjit Coleman, Jamie J |
author_facet | de Val, Jennifer Sohal, Gurjit Sarwar, Asif Ahmed, Haseeb Singh, Inderjit Coleman, Jamie J |
author_sort | de Val, Jennifer |
collection | PubMed |
description | INTRODUCTION: Hospital admissions from COVID-19 initially increased rapidly within the UK. National Health Service (NHS) field hospitals are part of a capacity building response built at great scale and speed to respond to the anticipated increased demand the NHS faces during this time. NHS Nightingale Hospital Birmingham (NHB) is modelled to treat mild to moderate (non-critical care) COVID-19 disease, to provide step-down capacity for patients in recovery, or for palliating patients in the dying phase of their disease in the Midlands. Opportunities and challenges presented for optimal medicines management (MM) during the development of the NHB are investigated, and a framework developed to support future NHS field hospitals of this model. METHODS: A team, comprised of an associate medical director, trust chief pharmacist and senior pharmacists iteratively developed a framework to convert the large non-hospital setting into a functioning NHS field hospital with standardised MM processes adjusted appropriately to cope with operational constraints in the pandemic situation. NHB has, because of its repurposing, both challenges and advantages affecting MM that influence development of the framework. Throughout implementation, a 7-week period between announcement and opening, there was continuous evaluation, external stakeholder validation and peer review. RESULTS: The PESTLE model, a mechanism of analysis to identify elements of a project environment (Political, Environmental, Social, Technological, Legal and Economic), was applied to identify influencing factors and support detailed project planning. Compliance with medicines legislation was at the forefront of all MM process development for the NHB field hospital. Internal factors were identified by the core MM team, resulting in a workforce, education & training and clinical pharmacy MM plan. DISCUSSION: MM processes are extensive and integral to NHS field hospitals. The presented framework of influencing factors may support future NHS field hospital development. It is pertinent to have a broad team working approach to any large-scale project such as outlined here, and suggest the identified factors be used as a core framework for development of any future MM processes in NHS field hospitals. |
format | Online Article Text |
id | pubmed-7788195 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-77881952021-01-14 Investigating the challenges and opportunities for medicines management in an NHS field hospital during the COVID-19 pandemic de Val, Jennifer Sohal, Gurjit Sarwar, Asif Ahmed, Haseeb Singh, Inderjit Coleman, Jamie J Eur J Hosp Pharm Original Research INTRODUCTION: Hospital admissions from COVID-19 initially increased rapidly within the UK. National Health Service (NHS) field hospitals are part of a capacity building response built at great scale and speed to respond to the anticipated increased demand the NHS faces during this time. NHS Nightingale Hospital Birmingham (NHB) is modelled to treat mild to moderate (non-critical care) COVID-19 disease, to provide step-down capacity for patients in recovery, or for palliating patients in the dying phase of their disease in the Midlands. Opportunities and challenges presented for optimal medicines management (MM) during the development of the NHB are investigated, and a framework developed to support future NHS field hospitals of this model. METHODS: A team, comprised of an associate medical director, trust chief pharmacist and senior pharmacists iteratively developed a framework to convert the large non-hospital setting into a functioning NHS field hospital with standardised MM processes adjusted appropriately to cope with operational constraints in the pandemic situation. NHB has, because of its repurposing, both challenges and advantages affecting MM that influence development of the framework. Throughout implementation, a 7-week period between announcement and opening, there was continuous evaluation, external stakeholder validation and peer review. RESULTS: The PESTLE model, a mechanism of analysis to identify elements of a project environment (Political, Environmental, Social, Technological, Legal and Economic), was applied to identify influencing factors and support detailed project planning. Compliance with medicines legislation was at the forefront of all MM process development for the NHB field hospital. Internal factors were identified by the core MM team, resulting in a workforce, education & training and clinical pharmacy MM plan. DISCUSSION: MM processes are extensive and integral to NHS field hospitals. The presented framework of influencing factors may support future NHS field hospital development. It is pertinent to have a broad team working approach to any large-scale project such as outlined here, and suggest the identified factors be used as a core framework for development of any future MM processes in NHS field hospitals. BMJ Publishing Group 2021-01 2020-12-04 /pmc/articles/PMC7788195/ /pubmed/33277234 http://dx.doi.org/10.1136/ejhpharm-2020-002364 Text en © European Association of Hospital Pharmacists 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage |
spellingShingle | Original Research de Val, Jennifer Sohal, Gurjit Sarwar, Asif Ahmed, Haseeb Singh, Inderjit Coleman, Jamie J Investigating the challenges and opportunities for medicines management in an NHS field hospital during the COVID-19 pandemic |
title | Investigating the challenges and opportunities for medicines management in an NHS field hospital during the COVID-19 pandemic |
title_full | Investigating the challenges and opportunities for medicines management in an NHS field hospital during the COVID-19 pandemic |
title_fullStr | Investigating the challenges and opportunities for medicines management in an NHS field hospital during the COVID-19 pandemic |
title_full_unstemmed | Investigating the challenges and opportunities for medicines management in an NHS field hospital during the COVID-19 pandemic |
title_short | Investigating the challenges and opportunities for medicines management in an NHS field hospital during the COVID-19 pandemic |
title_sort | investigating the challenges and opportunities for medicines management in an nhs field hospital during the covid-19 pandemic |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788195/ https://www.ncbi.nlm.nih.gov/pubmed/33277234 http://dx.doi.org/10.1136/ejhpharm-2020-002364 |
work_keys_str_mv | AT devaljennifer investigatingthechallengesandopportunitiesformedicinesmanagementinannhsfieldhospitalduringthecovid19pandemic AT sohalgurjit investigatingthechallengesandopportunitiesformedicinesmanagementinannhsfieldhospitalduringthecovid19pandemic AT sarwarasif investigatingthechallengesandopportunitiesformedicinesmanagementinannhsfieldhospitalduringthecovid19pandemic AT ahmedhaseeb investigatingthechallengesandopportunitiesformedicinesmanagementinannhsfieldhospitalduringthecovid19pandemic AT singhinderjit investigatingthechallengesandopportunitiesformedicinesmanagementinannhsfieldhospitalduringthecovid19pandemic AT colemanjamiej investigatingthechallengesandopportunitiesformedicinesmanagementinannhsfieldhospitalduringthecovid19pandemic |